U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07198113) titled 'COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)' on Sept. 19.
Brief Summary: The purpose of the study is to compare the clinical effectiveness and safety of newer inflammatory bowel disease (IBD) medications in anti-tumor necrosis factor (TNF) refractory patients with pediatric IBD (PIBD). Refractory means that there was no clinical response to anti-tumor necrosis factor (TNF) drugs or that the if there was a response, it is no longer present. The main question this study aims to answer is:
Are the newer medications used to treat IBD just as safe and effective for treating IBD in children.
Participants will already be taking ...